Search Results - "THOMPSON, Juliette"

Refine Results
  1. 1

    Critical appraisal of nonrandomized studies—A review of recommended and commonly used tools by Quigley, Joan M., Thompson, Juliette C., Halfpenny, Nicholas J., Scott, David A.

    Published in Journal of evaluation in clinical practice (01-02-2019)
    “…Rationale, aims, and objectives When randomized controlled trial data are limited or unavailable, or to supplement randomized controlled trial evidence, health…”
    Get full text
    Journal Article
  2. 2

    Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review by Riedel, Richard F, Jones, Robin L, Italiano, Antoine, Bohac, Chet, Thompson, Juliette C, Mueller, Kerstin, Khan, Zaeem, Pollack, Seth M, Van Tine, Brian A

    Published in Cancers (01-11-2018)
    “…Synovial sarcoma (SS) is an aggressive malignancy which accounts for approximately 5⁻10% of all soft-tissue sarcomas. SS has pathologic and genomic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The Economic Burden of Lupus Nephritis: A Systematic Literature Review by Thompson, Juliette C., Mahajan, Anadi, Scott, David A., Gairy, Kerry

    Published in Rheumatology and therapy. (01-02-2022)
    “…Introduction Few studies have evaluated the economic burden of lupus nephritis (LN). The aim of this systematic literature review (SLR) was to assess the…”
    Get full text
    Journal Article
  5. 5

    Glucagon‐like peptide‐1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta‐analysis by Singh, Sonal, Wright, Eugene E., Kwan, Anita Y. M., Thompson, Juliette C., Syed, Iqra A., Korol, Ellen E., Waser, Nathalie A., Yu, Maria B., Juneja, Rattan

    Published in Diabetes, obesity & metabolism (01-02-2017)
    “…Aims Since 2005, several glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have been approved to treat people with type 2 diabetes. These agents are…”
    Get full text
    Journal Article
  6. 6

    Burden of Interpandemic Influenza in Children Younger than 5 Years: A 25-Year Prospective Study by Neuzil, Kathleen M., Zhu, Yuwei, Griffin, Marie R., Edwards, Kathryn M., Thompson, Juliette M., Tollefson, Sharon J., Wright, Peter F.

    Published in The Journal of infectious diseases (15-01-2002)
    “…Many respiratory viruses cause morbidity in young children, but a licensed vaccine and effective oral therapy are available only for influenzavirus. To…”
    Get full text
    Journal Article
  7. 7

    Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials by Garcia Sanchez, Juan Jose, Thompson, Juliette, Scott, David A., Evans, Rachel, Rao, Naveen, Sörstadius, Elisabeth, James, Glen, Nolan, Stephen, Wittbrodt, Eric T., Abdul Sultan, Alyshah, Stefansson, Bergur V., Jackson, Dan, Abrams, Keith R.

    Published in Advances in therapy (01-01-2022)
    “…Delaying disease progression and reducing the risk of mortality are key goals in the treatment of chronic kidney disease (CKD). New drug classes to augment…”
    Get full text
    Journal Article
  8. 8

    Clinical Burden of Angiographic Vasospasm and Its Complications After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review by Chalet, François-Xavier, Briasoulis, Orestis, Manalastas, Eric J., Talbot, Darren A., Thompson, Juliette C., Macdonald, R. Loch

    Published in Neurology and therapy (01-04-2023)
    “…Introduction Angiographic vasospasm (VSP), the narrowing of intracranial arteries, is a complication of aneurysmal subarachnoid hemorrhage (aSAH) and often…”
    Get full text
    Journal Article
  9. 9

    Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review by Thompson, Juliette C., Chalet, François-Xavier, Manalastas, Eric J., Hawkins, Neil, Sarri, Grammati, Talbot, Darren A.

    Published in Neurology and therapy (01-06-2022)
    “…Introduction Cerebral vasospasm (VSP) is the leading risk factor of neurological deterioration (i.e., delayed cerebral ischemia [DCI] and cerebral infarction)…”
    Get full text
    Journal Article
  10. 10
  11. 11

    A practical approach to predict expansion of evidence networks: a case study in treatment-naive advanced melanoma by Halfpenny, Nicholas J A, Scott, David A, Thompson, Juliette C, Gurung, Binu, Quigley, Joan M

    Published in Melanoma research (01-02-2019)
    “…Network meta-analysis (NMA) is a statistical method used to produce comparable estimates of efficacy across a range of treatments that may not be compared…”
    Get full text
    Journal Article
  12. 12

    Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis by Scott, David A, Woods, Bethan, Thompson, Juliette C, Clark, James F, Hawkins, Neil, Chambers, Mike, Celli, Bartolome R, Calverley, Peter

    Published in BMC pulmonary medicine (11-11-2015)
    “…Increasing evidence suggests pharmacological treatments may impact on overall survival in Chronic Obstructive Pulmonary Disease (COPD) patients. Individual…”
    Get full text
    Journal Article
  13. 13

    Epidemiology and Clinical Impact of Parainfluenza Virus Infections in Otherwise Healthy Infants and Young Children < 5 Years Old by Reed, George, Jewett, Paula H., Thompson, Juliette, Tollefson, Sharon, Wright, Peter F.

    Published in The Journal of infectious diseases (01-04-1997)
    “…Over a 20-year period in a population of otherwise healthy children, respiratory viruses have been cultured from nasal wash specimens from each child with a…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Twenty Years of Outpatient Respiratory Syncytial Virus Infection: A Framework for Vaccine Efficacy Trials by Fisher, Randall G, Gruber, William C, Edwards, Kathryn M, Reed, George W, Tollefson, Sharon J, Thompson, Juliette M, Wright, Peter F

    Published in Pediatrics (Evanston) (01-02-1997)
    “…Respiratory syncytial virus (RSV) is the most important viral respiratory pathogen of infancy and childhood. Much has been written about inpatients with severe…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A Real-World Evidence Systematic Literature Review of Health-Related Quality of Life, Costs and Economic Evaluations in Newly-Diagnosed Multiple Myeloma Patients by Yong, Candice, Korol, Ellen, Khan, Zaeem, Lin, Huamao Mark, Thompson, Juliette, Valovicova, Veronika, Luptakova, Katarina, Seal, Brian

    Published in Blood (02-12-2016)
    “…Introduction Current treatment for multiple myeloma (MM) is not curative, but aims to provide patients with improved disease control to extend survival. Newly…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a [Beta]^sub 2^-adrenoceptor-independent mechanism by McCormick, Cecilia, Alexandre, Leo, Thompson, Juliette, Mutungi, Gabriel

    Published in Journal of applied physiology (1985) (01-12-2010)
    “…Although the acute actions of short-acting β...-adrenoceptor agonists on force production in isolated mammalian skeletal muscle fibers have been the subject of…”
    Get full text
    Journal Article